Home/Filings/4/A/0000899243-21-024951
4/A//SEC Filing

Smith-Whitley Kim 4/A

Accession 0000899243-21-024951

CIK 0001629137other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:05 PM ET

Size

10.7 KB

Accession

0000899243-21-024951

Insider Transaction Report

Form 4/AAmended
Period: 2021-06-01
Transactions
  • Award

    Restricted Stock Units

    2021-06-01+42,40042,400 total
    Common Stock (42,400 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
  • [F2]The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, subject to the Reporting Person's continuous service with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeother

Related Parties

1
  • filerCIK 0001860297

Filing Metadata

Form type
4/A
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:05 PM ET
Size
10.7 KB